Bionomics Limited - American De (BNOX) Financials
BNOX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 27.6 million | 6.3 million |
2023-06-30 | 28.5 million | 6.5 million |
2023-03-31 | 11.0 million | 1.4 million |
2022-12-31 | 38.4 million | 5.8 million |
BNOX Free Cash Flow and Stock based compensation
No data available :(
BNOX Net Income
No data available :(
BNOX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 11.7 million | - | - |
2023-06-30 | 12.1 million | - | 353994 |
2023-03-31 | 5.6 million | - | - |
2022-12-31 | 20.9 million | - | 418615 |
BNOX Shares Outstanding
BNOX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 3.8 million | 1.5 million | 35094 |
2023-06-30 | - | - | - | - |
2023-03-31 | 106101 | 3.0 million | 1.5 million | 36641 |
2022-12-31 | - | 4.9 million | 1.9 million | - |
BNOX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 9573 | 2.8 million |
2023-06-30 | - | - |
2023-03-31 | 173425 | 3.0 million |
2022-12-31 | 44895 | - |
BNOX
Price: $1
52 week price:
Earnings Per Share: -2.37 USD
P/E Ratio: -0.38
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1400
Market Capitalization: 11.0 million